Recent Cancer Drugs Approved by the FDA.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 398
- Publication type:
- Article
Works matching IS 21641153 AND DT 2020 AND VI 10 AND IP 6
Results: 7
1
2
HOPA ABSTRACTS 2020, PART IV.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 390
- Publication type:
- Article
3
Desensitization Permits Continued Trastuzumab and Ado-Trastuzumab Emtansine Therapy After Hypersensitivity Reaction.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 380
- By:
- Publication type:
- Article
4
Vaccination Rates in Patients with Hematologic Cancers After Hematopoietic Stem-Cell Transplant: A Single-Center Retrospective Study.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 370
- By:
- Publication type:
- Article
5
Evaluation of Inpatient Oral Chemotherapy: An Academic Medical Center Experience.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 359
- By:
- Publication type:
- Article
6
The Safety Profile of Mini-Dose Methotrexate for Graft-versus-Host Disease Prophylaxis: Is There a Place for Folinic Acid Rescue?
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 346
- By:
- Publication type:
- Article
7
Outcomes for Patients Receiving Ibrutinib with or without Antifungal Therapy.
- Published in:
- Journal of Hematology Oncology Pharmacy, 2020, v. 10, n. 6, p. 334
- By:
- Publication type:
- Article